LivaNova PLC (LIVN) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
LivaNova’s revenue went from $965M in fiscal 2016 to $1.4B in fiscal 2025, growth of about 4.1% a year.
Net income in fiscal 2025 was -$242M, a net margin of -17.5%; the best year in this period was 2024 with $63M.
Over the twelve months to September 30, 2026, revenue was $1.5B and net income $196M.
Free cash flow was $173M in fiscal 2025 and positive in 8 of the 10 years shown.
The diluted share count rose 11% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $1.3B | $1.2B | $1.0B | $1.0B | $934M | $1.1B | $1.1B | $1.0B | $965M |
| Gross profit | $1.0B | $940M | $853M | $756M | $707M | $706M | $595M | $724M | $734M | $652M | $560M |
| Operating income | $162M | $199M | $129M | -$68M | -$77M | -$784000 | -$274M | -$172M | -$248M | $96M | $33M |
| Net income | $196M | -$242M | $63M | $18M | -$86M | -$136M | -$349M | -$158M | -$189M | -$25M | -$63M |
| EPS (diluted) | $3.49 | $-4.45 | $1.16 | $0.32 | $-1.61 | $-2.68 | $-7.18 | $-3.26 | $-3.91 | $-0.52 | $-1.28 |
| R&D | $212M | $186M | $183M | $194M | $156M | $183M | $153M | $147M | $146M | $110M | $82M |
| Revenue growth | — | +10.7% | +8.7% | +12.9% | −1.3% | +10.8% | −13.8% | −2.1% | +9.3% | +4.9% | +230.9% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $238M | $254M | $183M | $75M | $70M | $103M | -$79M | -$91M | $120M | $91M | $90M |
| Capital spending | -$109M | -$81M | -$47M | -$35M | -$27M | -$25M | -$35M | -$25M | -$37M | -$33M | -$38M |
| Free cash flow | $129M | $173M | $136M | $40M | $43M | $77M | -$114M | -$116M | $83M | $58M | $52M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | $0 | $0 | $50M | $0 | $54M |
| Stock-based pay | $49M | $36M | $34M | $36M | $45M | $41M | $35M | $33M | $27M | $19M | $20M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $636M | $429M | $267M | $214M | $208M | $253M | $61M | $47M | $94M | $40M |
| Debt | — | $433M | $676M | $640M | $578M | $284M | $704M | $391M | $163M | $88M | $123M |
| Equity | — | $1.2B | $1.3B | $1.3B | $1.2B | $1.3B | $1.1B | $1.4B | $1.5B | $1.8B | $1.7B |
| Total assets | — | $2.6B | $2.5B | $2.4B | $2.3B | $2.2B | $2.4B | $2.4B | $2.5B | $2.5B | $2.3B |
| Shares (diluted) | 57M | 55M | 55M | 54M | 53M | 51M | 49M | 48M | 48M | 49M | 49M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 67.8% | 67.7% | 68.1% | 65.5% | 69.2% | 68.2% | 63.7% | 66.8% | 66.3% | 64.4% | 58.0% |
| Operating margin | 10.7% | 14.4% | 10.3% | -5.9% | -7.5% | -0.1% | -29.3% | -15.8% | -22.4% | 9.5% | 3.5% |
| Net margin | 13.0% | -17.5% | 5.0% | 1.5% | -8.4% | -13.1% | -37.3% | -14.5% | -17.1% | -2.5% | -6.5% |
| FCF margin | 8.6% | 12.5% | 10.8% | 3.5% | 4.2% | 7.4% | -12.2% | -10.7% | 7.5% | 5.8% | 5.4% |
| ROIC | — | 9.6% | 4.6% | -2.8% | -3.4% | -0.0% | -15.1% | -8.1% | -10.7% | 3.0% | 1.5% |
| ROE | — | -20.2% | 4.8% | 1.4% | -7.1% | -10.5% | -31.4% | -11.4% | -12.6% | -1.4% | -3.7% |
Frequently asked questions
What is LivaNova’s annual revenue?
$1.4B in fiscal 2025 and $1.5B over the twelve months to September 30, 2026.
How much profit does LivaNova make?
Net income was -$242M in fiscal 2025 (net margin -17.5%).
Is LivaNova’s revenue growing?
Yes: revenue rose 10.7% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.